Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Adults with Parkinson's Disease experience an array of challenges and changes in daily living, behaviors, and functioning throughout the progression of their condition. The investigators want to learn more about the effects of Parkinson's Disease on individuals' social behavior and quality of life (QoL) compared to people of the same age without Parkinson's Disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Parkinson's disease | This group includes adults who:
|
| |
| Neurotypical adults | This group includes adults who:
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No Intervention | Other | Observational study with no intervention |
|
| Measure | Description | Time Frame |
|---|---|---|
| Subjective Quality of Life | satisfaction with different aspects of life, such as health and social relationships | through study completion, an average of 1 year |
| Social Behavior | ability to interact with others | through study completion, an average of 1 year |
| Activities of Daily Living | ability to complete tasks to be independent | through study completion, an average of 1 year |
| Mental Health | depression and anxiety symptoms | through study completion, an average of 1 year |
| Cognition | memory and executive function challenges and strengths | through study completion, an average of 1 year |
Not provided
Not provided
Parkinson's disease group
Inclusion Criteria:
Exclusion Criteria:
Neurotypical group
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
The study includes both 40+ year old adults with Parkinson's disease and 40+ year old neurotypical adults
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Gregory Wallace, PhD | Contact | 202-994-8285 | ladn@gwu.edu |
| Name | Affiliation | Role |
|---|---|---|
| Gregory Wallace, PhD | George Washington University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The George Washington University | Recruiting | Washington D.C. | District of Columbia | 20052 | United States |
Currently, there is no plan to share participant data with other researchers.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |